Diabetes
Conference Coverage
Antidepressants ‘don’t blunt’ semaglutide and weight loss
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
From the Journals
Alert! A decade of type 2 diabetes shortens life by 3.5 years
“I personally think the findings show that we should treat cardiovascular risk factors more aggressively in people diagnosed with [type 2]...
From the Journals
Redefining CVD risk: Cardiovascular-kidney-metabolic (CKM) syndrome
“Clearly defining the patient with CKM syndrome, and providing new approaches for CKM syndrome staging and risk prediction, will help health care...
Conference Coverage
Weight loss with semaglutide maintained for up to 3 years
“Importantly, these effects were sustained for up to 3 years, supporting the use of once weekly semaglutide for the long-term management of type 2...
Conference Coverage
Echocardiography boosts prognostic power in T1D
“MPI has been around for many years, but our technique is rather novel” and has high intra- and inter-observer reproducibility. “It’s highly...
Commentary
Beyond A1c: Implementing the new ESC 2023 guidelines
Controversially, the updated ESC guidance suggests the use of metformin only in patients with type 2 diabetes and atherosclerotic cardiovascular...
Conference Coverage
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized...
Conference Coverage
Heart attack deaths static in those with type 1 diabetes
“Clinicians have to be aware of the absence of the declined mortality trend in people with type 1 diabetes having a first-time myocardial...
Conference Coverage
Low-dose aspirin cuts type 2 diabetes risk in over-65s
“At this time, our findings are exploratory but ignite the debate of the important role that anti-inflammatory approaches may play in preventing...
Conference Coverage
Screening finds high rates of CVD in diabetes, COPD patients
The study tested a “very simple” symptom questionnaire as the initial screening phase, yet resulted in a CVD diagnostic rate that was two- to...
Latest News
Medicare announces 10 drugs targeted for price cuts in 2026
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.